Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
107,573,681
-
Number of holders
-
25
-
Total 13F shares, excl. options
-
2,755,859
-
Shares change
-
-456,075
-
Total reported value, excl. options
-
$4,986,901
-
Value change
-
-$1,175,482
-
Number of buys
-
9
-
Number of sells
-
-7
-
Price
-
$1.81
Significant Holders of VOLITIONRX LTD - Common Stock, par value $0.001 per share (VNRX) as of Q4 2018
28 filings reported holding VNRX - VOLITIONRX LTD - Common Stock, par value $0.001 per share as of Q4 2018.
VOLITIONRX LTD - Common Stock, par value $0.001 per share (VNRX) has 25 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2,755,859 shares
of 107,573,681 outstanding shares and own 2.56% of the company stock.
Largest 10 shareholders include Lagoda Investment Management, L.P. (1,643,714 shares), Vanguard Group Inc (318,970 shares), BRIDGEWAY CAPITAL MANAGEMENT INC (224,400 shares), GEODE CAPITAL MANAGEMENT, LLC (100,890 shares), MORGAN STANLEY (82,250 shares), Leisure Capital Management (66,361 shares), CREDIT SUISSE AG/ (65,000 shares), OPPENHEIMER & CO INC (38,652 shares), NORTHERN TRUST CORP (38,032 shares), and SUSQUEHANNA INTERNATIONAL GROUP, LLP (29,391 shares).
This table shows the top 25 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.